Bristol Income Before Tax from 2010 to 2025

BMY Stock  USD 59.19  1.86  3.05%   
Bristol Myers Income Before Tax yearly trend continues to be fairly stable with very little volatility. Income Before Tax is likely to outpace its year average in 2025. During the period from 2010 to 2025, Bristol Myers Income Before Tax regression line of annual values had significance of  0.26 and arithmetic mean of  2,591,246,875. View All Fundamentals
 
Income Before Tax  
First Reported
1990-03-31
Previous Quarter
1.7 B
Current Value
175 M
Quarterly Volatility
1.6 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.1 B, Interest Expense of 2 B or Selling General Administrative of 8.8 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0274 or PTB Ratio of 6.94. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Income Before Tax Growth Pattern

Below is the plot of the Income Before Tax of Bristol Myers Squibb over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on Bristol Myers income statement and is an important metric when analyzing Bristol Myers Squibb profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is Bristol Myers' Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Income Before Tax10 Years Trend
Slightly volatile
   Income Before Tax   
       Timeline  

Bristol Income Before Tax Regression Statistics

Arithmetic Mean2,591,246,875
Coefficient Of Variation215.43
Mean Deviation4,104,097,266
Median4,975,000,000
Standard Deviation5,582,219,822
Sample Variance31161178.1T
Range16.8B
R-Value(0.30)
Mean Square Error30358872.9T
R-Squared0.09
Significance0.26
Slope(353,109,926)
Total Sum of Squares467417672.1T

Bristol Income Before Tax History

2025-8 B
2024-8.4 B
20238.4 B
20227.7 B
20218.1 B
2020-6.9 B
2019B

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Income Before Tax, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Before Tax-8.4 B-8 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.